<< Back To Biopharmaceuticals
Antibody Therapies
BioSurgery
Critical Care
Hemophilia
FLOSEAL is indicated in surgical procedures (other than opthalmic) as an adjunct to hemostasis when control of bleeding by ligature or conventional procedures is ineffective or impractical.
COSEAL is indicated for use in vascular reconstructions to achieve adjunctive hemostasis by mechanically sealing areas of leakage.
TISSEEL is indicated for use as an adjunct to hemostasis in surgeries involving cardiopulmonary bypass and treatment of splenic injuries due to blunt or penetrating trauma to the abdomen, when control of bleeding by conventional surgical techniques, including suture, ligature and cautery is ineffective or impractical. TISSEEL has been shown to be an effective sealant as an adjunct in the closure of colostomies. TISSEEL is a satisfactory hemostatic agent in fully heparinized patients undergoing cardiopulmonary bypass.
ADEPT Adhesion Reduction Solution is indicated for use intraperitoneally as an adjunct to good surgical technique for the reduction of post-surgical adhesions in patients undergoing gynecologic laparoscopic adhesiolysis.
GELFOAM PLUS Hemostasis Kit is intended as a hemostatic device for surgical procedures when control of capillary, venous, and arteriolar bleeding by pressure, ligature, and other conventional procedures is either ineffective or impractical. Thrombin (Human) used without the Gelfoam Sterile Sponge is not indicated for hemostasis.
ARTISS is indicated to adhere autologous skin grafts to surgically prepared wound beds resulting from burns in adult and pediatric populations. ARTISS is not indicated for hemostasis.
![FLOSEAL [Hemostatic Matrix]](/images/products/biopharmaceuticals/floseal.jpg)
![COSEAL [Surgical Sealant]](/images/products/biopharmaceuticals/coseal.jpg)
![TISSEEL [Fibrin Sealant]](/images/products/biopharmaceuticals/Icontisseel.jpg)
![Adept Adhesion Reduction Solution [4% Icodextrin]](/images/products/biopharmaceuticals/AdeptIcon.jpg)
Print this page
